GlassScriptPhysician profile
Howard S Berlin
NPI 1568426856
$936.73
in general payments reported to CMS, 2019-2025
17 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $81.10 · 2021: $35.67 · 2023: $133 · 2024: $103 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $127.12 | 2023-2024 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.00 | 2019 | |
| Alcon Vision LLC | $90.93 | 2020-2025 | Eysuvis, Rocklatan |
| Aerie Pharmaceuticals, INC. | $76.73 | 2019-2020 | |
| Amgen INC. | $73.32 | 2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $67.03 | 2019 | |
| Abbvie INC. | $65.16 | 2024-2025 | |
| Dompe US, INC. | $63.65 | 2025 | Oxervate |
| Astellas Pharma US INC | $58.19 | 2025 | Izervay |
| Apellis Pharmaceuticals, INC. | $45.35 | 2025 | Syfovre |
| Bausch & Lomb Americas INC. | $41.80 | 2024 | Xiidra, Miebo |
| Harrow Eye, LLC | $27.30 | 2025 | Vevye |
| Akorn Operating Company LLC | $22.98 | 2021 | |
| Biotissue Holdings INC. | $22.69 | 2025 | |
| Mallinckrodt Hospital Products INC. | $21.79 | 2025 | Acthar |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $20.00 | 2023 | |
| Allergan, INC. | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Berlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.